The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis
Open accessAbstract
BACKGROUND: Characterization of the mesenchymal stromal cell (MSC) safety profile is important as this novel therapy continues to be evaluated in clinical trials for various inflammatory conditions. Due to an increase in published randomized controlled trials (RCTs) from 2012-2019, we performed an updated systematic review to further characterize the MSC safety profile. METHODS: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and Web of Science (to May 2018) were searched. RCTs that compared intravascular delivery of MSCs to controls in adult populations were included. Pre-specified adverse events were grouped according to: (1) immediate, (2) infection, (3) thrombotic/embolic, and (4) longer-term events (mortality, malignancy). Adverse events were pooled and meta-analyzed by fitting inverse-variance binary random effects models. Primary and secondary clinical efficacy endpoints were summarized descriptively. FINDINGS: = 0%, 0%, 0%, 0%, 0%). No included trials were ended prematurely due to safety concerns. INTERPRETATIONS: MSC therapy continues to exhibit a favourable safety profile. Future trials should continue to strengthen study rigor, reporting of MSC characterization, and adverse events. FUNDING: Stem Cell Network, Ontario Institute for Regenerative Medicine and Ontario Research Fund.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues.
Friedenstein, A. J., Kv, P., KUROLESOVA, A. I., & Frolova, G. P. (1968) · PubMed · Cited by 1,921
HETEROTOPIC TRANSPLANTS OF BONE MARROW
FRIEDENSTEIN, A. J., PETRAKOVA, K. V., KUROLESOVA, A. I., & FROLOVA, G. P. (1968) · Transplantation · doi:10.1097/00007890-196803000-00009 · Cited by 1,699
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593
Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N., Strumpf, R. K., Schulman, S. P., Gerstenblith, G., DeMaria, A. N., Denktas, A. E., Gammon, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.06.055 · Cited by 1,350
Lalu, M. M., McIntyre, L., Pugliese, C., Fergusson, D., Winston, B. W., Marshall, J. C., Granton, J., Stewart, D. J., & Canadian Critical Care Trials Group (2012) · PLoS ONE · doi:10.1371/journal.pone.0047559 · Cited by 1,146
Self-citationWhy are MSCs therapeutic? New data: new insight
Caplan, A. (2009) · The Journal of Pathology · doi:10.1002/path.2469 · Cited by 1,114
Lee, J. S., Hong, J. M., Moon, G. J., Lee, P. H., Ahn, Y. H., & Bang, O. Y. (2010) · Stem Cells · doi:10.1002/stem.430 · Cited by 779
Mei, S. H. J., Haitsma, J. J., Dos Santos, C. C., Deng, Y., Lai, P. F. H., Slutsky, A. S., Liles, W. C., & Stewart, D. J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0010oc · Cited by 721
Self-citationMei, S. H. J., McCarter, S. D., Deng, Y., Parker, C. H., Liles, W. C., & Stewart, D. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040269 · Cited by 619
Self-citationMatthay, M. A., Calfee, C. S., Zhuo, H., Thompson, B. T., Wilson, J. G., Levitt, J. E., Rogers, A. J., Gotts, J. E., Wiener-Kronish, J. P., Bajwa, E. K., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30418-1 · Cited by 600
Bartolucci, J., Verdugo, F. J., González, P. L., Larrea, R. E., Abarzua, E., Goset, C., Rojo, P., Palma, I., Lamich, R., Pedreros, P. A., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310712 · Cited by 487
Moll, G., Ankrum, J. A., Kamhieh-Milz, J., Bieback, K., Ringdén, O., Volk, H.-D., Geissler, S., & Reinke, P. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.12.006 · Cited by 440
Zheng, G., Huang, L., Tong, H., Shu, Q., Hu, Y., Ge, M., Deng, K., Zhang, L., Zou, B., Cheng, B., et al. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-39 · Cited by 428
A Placebo-Controlled, Randomized Trial of Mesenchymal Stem Cells in COPD
Weiss, D. J., Casaburi, R., Flannery, R., LeRoux-Williams, M., & Tashkin, D. P. (2013) · Chest · doi:10.1378/chest.12-2094 · Cited by 423
Ning, H., Yang, F., Jiang, M., Hu, L., Feng, K., Zhang, J., Yu, Z., Li, B., Xu, C., Li, Y., et al. (2008) · Leukemia · doi:10.1038/sj.leu.2405090 · Cited by 407
Shi, M., Zhang, Z., Xu, R., Lin, H., Fu, J., Zou, Z., Zhang, A., Shi, J., Chen, L., Lv, S., et al. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0034 · Cited by 374
Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
Moll, G., Rasmusson-Duprez, I., von Bahr, L., Connolly-Andersen, A.-M., Elgue, G., Funke, L., Hamad, O. A., Lönnies, H., Magnusson, P. U., Sanchez, J., et al. (2012) · Stem Cells · doi:10.1002/stem.1111 · Cited by 357
Defining the risks of mesenchymal stromal cell therapy
Prockop, D. J., Brenner, M., Fibbe, W. E., Horwitz, E., Le Blanc, K., Phinney, D. G., Simmons, P. J., Sensebe, L., & Keating, A. (2010) · Cytotherapy · doi:10.3109/14653249.2010.507330 · Cited by 339
Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells
Carlsson, P.-O., Schwarcz, E., Korsgren, O., & Le Blanc, K. (2015) · Diabetes · doi:10.2337/db14-0656 · Cited by 315
Suk, K. T., Yoon, J., Kim, M. Y., Kim, C. W., Kim, J. K., Park, H., Hwang, S. G., Kim, D. J., Lee, B. S., Lee, S. H., et al. (2016) · Hepatology · doi:10.1002/hep.28693 · Cited by 303
Lin, B., Chen, J., Qiu, W., Wang, K., Xie, D., Chen, X., Liu, Q., Peng, L., Li, J., Mei, Y., et al. (2017) · Hepatology · doi:10.1002/hep.29189 · Cited by 288
Álvaro-Gracia, J. M., Jover, J. A., García-Vicuña, R., Carreño, L., Alonso, A., Marsal, S., Blanco, F., Martínez-Taboada, V. M., Taylor, P., Martín-Martín, C., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208918 · Cited by 264
Hu, J., Yu, X., Wang, Z., Wang, F., Wang, L., Gao, H., Chen, Y., Zhao, W., Jia, Z., Yan, S., et al. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej12-0343 · Cited by 248
A randomized trial of mesenchymal stem cells in multiple system atrophy
Lee, P. H., Lee, J. E., Kim, H., Song, S. K., Lee, H. S., Nam, H. S., Cheong, J., Jeong, Y., Park, H., Kim, D. J., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23612 · Cited by 234
Gao, L. R., Chen, Y., Zhang, N. K., Yang, X. L., Liu, H. L., Wang, Z. G., Yan, X. Y., Wang, Y., Zhu, Z. M., Li, T. C., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0399-z · Cited by 221
Lee, P., Kim, J., Bang, O., Ahn, Y., Joo, I., & Huh, K. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100386 · Cited by 217
Gao, L., Zhang, Y., Hu, B., Liu, J., Kong, P., Lou, S., Su, Y., Yang, T., Li, H., Liu, Y., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.3642 · Cited by 185
Lee, J.-W., Lee, S.-H., Youn, Y.-J., Ahn, M.-S., Kim, J.-Y., Yoo, B.-S., Yoon, J., Kwon, W., Hong, I.-S., Lee, K., et al. (2014) · Journal of Korean Medical Science · doi:10.3346/jkms.2014.29.1.23 · Cited by 179
Mesenchymal stem cells for acute lung injury: Preclinical evidence
Matthay, M. A., Goolaerts, A., Howard, J. P., & Woo Lee, J. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181f1ff1d · Cited by 178
Zhang, J., Lv, S., Liu, X., Song, B., & Shi, L. (2018) · Gut and Liver · doi:10.5009/gnl17035 · Cited by 170
Tompkins, B. A., DiFede, D. L., Khan, A., Landin, A. M., Schulman, I. H., Pujol, M. V., Heldman, A. W., Miki, R., Goldschmidt-Clermont, P. J., Goldstein, B. J., et al. (2017) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx137 · Cited by 169
Chen, S., Wu-wang, F., Qian, J., et al. (2004) · PubMed · Cited by 163
Fernández, O., Izquierdo, G., Fernández, V., Leyva, L., Reyes, V., Guerrero, M., León, A., Arnaiz, C., Navarro, G., Páramo, M. D., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0195891 · Cited by 161
Salama, H., Zekri, A.-R. N., Medhat, E., Al Alim, S. A., Ahmed, O. S., Bahnassy, A. A., Lotfy, M. M., Ahmed, R., & Musa, S. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt459 · Cited by 160
LUBLIN, F. D., Bowen, J. D., Huddlestone, J., Kremenchutzky, M., Carpenter, A., Corboy, J. R., Freedman, M. S., Krupp, L., Paulo, C., HARIRI, R. J., et al. (2014) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2014.08.002 · Cited by 151
Deng, D., Zhang, P., Guo, Y., & Lim, T. O. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211073 · Cited by 148
Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery
Swaminathan, M., Stafford‐Smith, M., Chertow, G. M., Warnock, D. G., Paragamian, V., Brenner, R. M., Lellouche, F., Fox‐Robichaud, A., Atta, M. G., Melby, S. J., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016101150 · Cited by 130
Kuzmina, L. A., Петинати, Н. А., Parovichnikova, E. N., Lubimova, L. S., Грибанова, Е. О., Gaponova, T. V., Shipounova, I. N., Zhironkina, O. A., Bigildeev, A., Svinareva, D. A., et al. (2011) · Stem Cells International · doi:10.1155/2012/968213 · Cited by 129
Skyler, J. S., Fonseca, V. A., Segal, K. R., & Rosenstock, J. (2015) · Diabetes Care · doi:10.2337/dc14-2830 · Cited by 129
Xu, L., Gong, Y., Wang, B., Shi, K., Hou, Y., Wang, L., Lin, Z., Han, Y., Lu, L., Chen, D., et al. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12653 · Cited by 122
A Pilot Study of Mesenchymal Stem Cell Therapy for Acute Liver Allograft Rejection
Shi, M., Liu, Z., Wang, Y., Xu, R., Sun, Y., Zhang, M., Yu, X., Wang, H., Meng, L., Su, H., et al. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0134 · Cited by 122
Long term effect and safety of Wharton's jelly-derived mesenchymal stem cells on type 2 diabetes
Hu, J., Wang, Y., Gong, H., Yu, C., Guo, C., Wang, F., Yan, S., & Xu, H. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3544 · Cited by 113
Chullikana, A., Majumdar, A. S., Gottipamula, S., Krishnamurthy, S., Kumar, A. S., Prakash, V. S., & Gupta, P. K. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.10.009 · Cited by 108
Perlee, D., van Vught, L. A., Scicluna, B. P., Maag, A., Lutter, R., Kemper, E. M., Veer, C. V. ′., Punchard, M. A., González, J., Richard, M. P., et al. (2018) · Stem Cells · doi:10.1002/stem.2891 · Cited by 104
Mesenchymal Stem Cell Therapy for Cardiac Repair
Boyle, A., McNiece, I., & Hare, J. M. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-705-1_5 · Cited by 102
Gao, L. R., Pei, X. T., Ding, Q. A., Chen, Y., Zhang, N. K., Chen, H. Y., Wang, Z. G., Wang, Y. F., Zhu, Z. M., Li, T. C., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.04.112 · Cited by 97
Liu, K., Chen, Y., Zeng, Y. C., Xu, L., Liu, D., Chen, H., Zhang, X., Han, W., Wang, Y., Zhao, T., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0447 · Cited by 92
Yang, Y., He, X., Zhao, R., Guo, W., Zhu, M., Xing, W., Jiang, D., Liu, C., & Xu, X. M. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1541-4 · Cited by 91
Zhang, Z., Fu, J., Xu, X., Wang, S., Xu, R., Zhao, M., Nie, W., Wang, X., Zhang, J., Li, T., et al. (2013) · AIDS · doi:10.1097/qad.0b013e32835fab77 · Cited by 85
Effects of Freeze–Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression
Hoogduijn, M. J., de Witte, S. F. H., Luk, F., Vroonhoven, M. C. G. N. V. D. H.-V., Ignatowicz, L., Catar, R. A., Strini, T., Korevaar, S. S., van IJcken, W. F. J., Betjes, M. G. H., et al. (2016) · Stem Cells and Development · doi:10.1089/scd.2015.0329 · Cited by 75
Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohnʼs Disease
MELMED, G. Y., Pandak, W. M., Casey, K. J., Abraham, B. P., Valentine, J. F., Schwartz, D. A., Awais, D., Bassan, I., Lichtiger, S., Sands, B. E., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000441 · Cited by 69
Zhao, X., Xu, Y., Zhu, Z., Gao, C., & Shi, Y. N. (2015) · Genetics and Molecular Research · doi:10.4238/2015.april.10.11 · Cited by 63
Tsang, K. S., Ng, C. P. S., Zhu, X. L., Wong, G. K. C., Lu, G., Ahuja, A. T., Wong, K. S. L., Ng, H. K., & Poon, W. S. (2017) · World Journal of Stem Cells · doi:10.4252/wjsc.v9.i8.133 · Cited by 49
Administration of bone marrow stromal cells in sepsis attenuates sepsis-related coagulopathy
Tan, L., Huang, Y., Pan, X., Quan, S., Xu, S., Li, D., Song, L., Zhang, X., Chen, W., & Pan, J. (2016) · Annals of Medicine · doi:10.3109/07853890.2016.1157725 · Cited by 25
Zhang, D. (2017) · Genetics and Molecular Research · doi:10.4238/gmr16019352 · Cited by 16
Cited by
Lanzoni, G., Linetsky, E., Correa, D., Messinger Cayetano, S., Alvarez, R. A., Kouroupis, D., Alvarez Gil, A., Poggioli, R., Ruiz, P., Marttos, A. C., et al. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0472 · Cited by 404
Meng, F., Xu, R., Wang, S., Xu, Z., Zhang, C., Li, Y., Yang, T., Shi, L., Fu, J., Jiang, T., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00286-5 · Cited by 323
Zhuang, W.-Z., Lin, Y.-H., Su, L.-J., Wu, M.-S., Jeng, H.-Y., Chang, H.-C., Huang, Y.-H., & Ling, T.-Y. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00725-7 · Cited by 258
The issue of heterogeneity of MSC-based advanced therapy medicinal products–a review
Česnik, A. B., & Švajger, U. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1400347 · Cited by 128
Mesenchymal stem cell immunomodulation: in pursuit of controlling COVID-19 related cytokine storm
Song, N., Wakimoto, H., Rossignoli, F., Bhere, D., Ciccocioppo, R., Chen, K.-S., Khalsa, J. K., Mastrolia, I., Samarelli, A. V., Dominici, M., et al. (2021) · Stem Cells · doi:10.1002/stem.3354 · Cited by 62
Metadata
- Authors
- Thompson, M., Mei, S. H. J., Wolfe, D., Champagne, J., Fergusson, D., Stewart, D. J., Sullivan, K. J., Doxtator, E., Lalu, M., English, S. W., Granton, J., Hutton, B., Marshall, J., Maybee, A., Walley, K. R., Santos, C. D., Winston, B., & McIntyre, L.
- Venue
- EClinicalMedicine
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 19
- Pages
- 100249
- ISSN
- 2589-5370 (ISSN-L)
- OpenAlex
- W2999396804
- Cited by
- 283
- References
- 59
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.